CTOs on the Move

Qualicaps

www.qualicaps.com

 
Qualicaps is a global supplier of two-piece capsules and related encapsulation equipment. Employees are our most valuable internal asset and we foster a creative, challenging environment in which personal and professional achievements are recognized.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.qualicaps.com
  • 6505 Franz Warner Pkwy
    Whitsett, NC USA 27377
  • Phone: 336.449.7300

Executives

Name Title Contact Details

Similar Companies

JDS Pharmaceuticals

JDS Pharmaceuticals is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dr. Thompson's Inc

Dr. Thompson's Inc is a Westerville, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Zeno Health

Mumbais #1 Generic Medicine Pharmacy 100+ Stores | 200 Crore+ Savings Delivered | Trusted by over 15 Lakhs+ Customer

RedPath Integrated Pathology, Inc

RedPath Integrated Pathology, Inc. is a Pittsburgh-based molecular diagnostics laboratory focused on providing novel solutions for clinicians. RedPath’s patented PathFinderTG® platform produces mutational profiles to help physicians resolve complex diagnostic dilemmas in patients who are at risk of cancer. RedPath performs all clinical testing and R&D in its state-of-the-art, CLIA-certified and CAP-accredited laboratory. The PathFinderTG platform is supported by more than 20 years of scientific and clinical research, and studies using it have been published in more than 200 peer-reviewed journals, including The New England Journal of Medicine. Based on the strong clinical data supporting this platform, RedPath has received positive coverage decisions from Medicare and private payers.

Everest Medicines

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in mainland China and other Asian territories. We strive to be the partner of choice for innovative companies around the world with products that address critical unmet medical needs for patients in Greater China and have a high probability of market approval. The Everest Medicines team has deep expertise and extensive track record of high quality clinical development, regulatory affairs, CMC, business development and operations both in China and with leading global pharmaceutical companies. The company`s Series A round was led by C-Bridge Capital, a top-tier China healthcare private equity firm, with US $800 million under management.